| 000 | 01806 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518004955.0 | ||
| 264 | 0 | _c20190321 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a2213-2317 | ||
| 024 | 7 |
_a10.1016/j.redox.2018.10.020 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMotterlini, Roberto | |
| 245 | 0 | 0 |
_aHYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide. _h[electronic resource] |
| 260 |
_bRedox biology _c01 2019 |
||
| 300 |
_a334-348 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Inflammatory Agents _xpharmacology |
| 650 | 0 | 4 |
_aAntioxidants _xmetabolism |
| 650 | 0 | 4 |
_aCarbon Monoxide _xmetabolism |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCytokines _xgenetics |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aHeme Oxygenase-1 _xgenetics |
| 650 | 0 | 4 |
_aInflammation _xdrug therapy |
| 650 | 0 | 4 |
_aInflammation Mediators _xmetabolism |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadverse effects |
| 650 | 0 | 4 |
_aMacrophages _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMicroglia _xdrug effects |
| 650 | 0 | 4 |
_aNF-E2-Related Factor 2 _xgenetics |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 700 | 1 | _aNikam, Aniket | |
| 700 | 1 | _aManin, Sylvie | |
| 700 | 1 | _aOllivier, Anthony | |
| 700 | 1 | _aWilson, Jayne Louise | |
| 700 | 1 | _aDjouadi, Sabrina | |
| 700 | 1 | _aMuchova, Lucie | |
| 700 | 1 | _aMartens, Thierry | |
| 700 | 1 | _aRivard, Michael | |
| 700 | 1 | _aForesti, Roberta | |
| 773 | 0 |
_tRedox biology _gvol. 20 _gp. 334-348 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.redox.2018.10.020 _zAvailable from publisher's website |
| 999 |
_c29008252 _d29008252 |
||